Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Prockop, Darwin J  [Clear All Filters]
2013
Bartosh TJ, Ylöstalo JH, Bazhanov N, Kuhlman J, Prockop DJ. Dynamic compaction of human mesenchymal stem/precursor cells (MSC) into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6 and STC1). Stem Cells. 2013.
Prockop DJ. Two Negative Feedback Loops Place Mesenchymal Stem/Stromal Cells (MSCs) at the Center of Early Regulators of Inflammation. Stem Cells. 2013.
2014
Xie J, Broxmeyer HE, Feng D, Schweitzer KS, Yi R, Cook TG, Chitteti BR, Barwinska D, Traktuev DO, Van Demark MJ, et al. Human Adipose-derived Stem Cells Ameliorate Cigarette Smoke-induced Murine Myelosuppression via TSG-6. Stem Cells. 2014.
McFerrin HE, Olson SD, Gutschow MV, Semon JA, Sullivan DE, Prockop DJ. Rapidly Self-Renewing Human Multipotent Marrow Stromal Cells (hMSC) Express Sialyl Lewis X and Actively Adhere to Arterial Endothelium in a Chick Embryo Model System. PLoS One. 2014;9(8):e105411.
Reger RL, Prockop DJ. Should Publications on Mesenchymal Stem/Progenitor Cells Include In-Process Data on the Preparation of the Cells?. Stem Cells Transl Med. 2014.
2015
Prockop DJ. Hardly Tendentious - Repairing Like with Like. N Engl J Med. 2015;373(14):1371-1372.
Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, et al. International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 2015.
Weiss DJ, Chambers D, Giangreco A, Keating A, Kotton D, Lelkes PI, Wagner DE, Prockop DJ. An Official American Thoracic Society Workshop Report: Stem Cells and Cell Therapies in Lung Biology and Diseases. Ann Am Thorac Soc. 2015;12(4):S79-S97.
2016
Prockop DJ. The exciting prospects of new therapies with mesenchymal stromal cells. Cytotherapy. 2016.